Figure 5

![Figure 5: Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue.]()

> Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." *Advanced science (Weinheim, Baden-Wurttemberg, Germany)*, 2024. PMID: [39159301](https://pubmed.ncbi.nlm.nih.gov/39159301/)

<figure>
  <img src="" alt="Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue." />
  <figcaption>Figure 5. Western blot or gene expression data from the liraglutide-Myo1c/Dock5 study quantify changes in key signaling proteins associated with diabetic wound repair. Downstream effectors of the GLP-1 pathway are activated in treated wound tissue.<br>  Source: Qian Zhang et al. "Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5.." <em>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39159301/">39159301</a></figcaption>
</figure>